Yilong Zou
- Cancer Research top 1%
- Cancer, Lipids, and Metabolism 6
-
- Ferroptosis and cancer prognosis 6
- Brain Metastases and Treatment 2
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research 2
- Cancer Cells and Metastasis 2
- Molecular Biology top 5%
- RNA modifications and cancer 5
- TGF-β signaling in diseases 3
- Immunology top 5%
-
- Caveolin-1 and cellular processes 2
- Co-authors
- Joan MassaguéStuart L. SchreiberJie SuAmy DeikClary B. ClishJohn K. EatonHaoxin LiJohn G. Doench
- Partner nations
- United StatesChinaSpain
In The Last Decade
Yilong Zou
29 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Cancer Research 1.4k
- Pulmonary and Respiratory Medicine 1.6k
- Oncology 1.2k
- Molecular Biology 2.4k
- Immunology 432
Countries citing papers authored by Yilong Zou
This map shows the geographic impact of Yilong Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yilong Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yilong Zou more than expected).
Fields of papers citing papers by Yilong Zou
This network shows the impact of papers produced by Yilong Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yilong Zou. The network helps show where Yilong Zou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yilong Zou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 16 | |
| 6 | ACSL4 and polyunsaturated lipids support metastatic extravasation and colonizationbreakdown → | 2024 | 64 |
| 7 | 2023 | 7 | |
| 8 | 2023 | 23 | |
| 9 | 2022 | 12 | |
| 10 | 2021 | 25 | |
| 11 | Cytochrome P450 oxidoreductase contributes tophospholipid peroxidation in ferroptosisbreakdown → | 2020 | 565 |
| 12 | 2020 | 26 | |
| 13 | TGF-β orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1breakdown → | 2020 | 359 |
| 14 | 2019 | 72 | |
| 15 | 2019 | 47 | |
| 16 | 2017 | 238 | |
| 17 | TGF-β Tumor Suppression through a Lethal EMTbreakdown → | 2016 | 458 |
| 18 | Therapy-induced tumour secretomes promote resistance and tumour progressionbreakdown → | 2015 | 364 |
| 19 | 2014 | 112 | |
| 20 | 2013 | 321 |
About Yilong Zou
Yilong Zou is a scholar working on Cancer Research, Molecular Biology and Hepatology, having authored 30 papers that have together received 4.1k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (6 papers), Cancer, Lipids, and Metabolism (6 papers), RNA modifications and cancer (5 papers), TGF-β signaling in diseases (3 papers), Brain Metastases and Treatment (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Cancer Cells and Metastasis (2 papers) and Caveolin-1 and cellular processes (2 papers). The work is most often cited by research in Cancer Research (1.4k citations), Pulmonary and Respiratory Medicine (1.6k citations) and Oncology (1.2k citations). Yilong Zou has collaborated with scholars based in United States, China and Spain. Frequent co-authors include Joan Massagué, Stuart L. Schreiber, Jie Su, Amy Deik, Clary B. Clish, John K. Eaton, Haoxin Li, John G. Doench, Yun-Han Huang and Weiping Shu. Their work appears in journals such as Nature, Cell and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.